Time-restricted Eating in Survivors Trial
Launched by UNIVERSITY OF ALBERTA · Dec 2, 2022
Trial Information
Current as of January 16, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • history of early-stage (I-III) breast cancer
- • completed anthracycline-based chemotherapy 1-6 years earlier
- • aged ≥60 years
- • had a body mass index (BMI) \>25 kg/m2
- Exclusion Criteria:
- • taking lipid, glucose, or weight-lowering medications
- • contraindications to maximal exercise testing or research MRI
- • unstable thyroid disorder
- • self-reported history of an eating disorder
- • self-reported diagnosis of type 1 or 2 diabetes
- • weight loss of ≥15 lbs in previous 3 months
- • working night shifts
- • could not provide consent in English
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials